Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single‐centre experience
Abstract Aims Heart failure with reduced ejection fraction (HFrEF) is associated with excessive sympathetic and impaired parasympathetic activity. The Barostim Neo™ device is used for electronical baroreflex activation therapy (BAT) to counteract autonomic nervous system dysbalance. Randomized trial...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Oxford University Press
2023-12-01
|
| Серія: | ESC Heart Failure |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1002/ehf2.14508 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|